Pandey, G., Yanover, C., Miller-Jenkins, L., Garfield, S., Cole, S., Curran, J., . . . Reed, E. (2013). Endogenous factor VIII synthesis from the intron 22-inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A.
Chicago Style (17th ed.) CitationPandey, G., et al. Endogenous Factor VIII Synthesis from the Intron 22-inverted F8 Locus May Modulate the Immunogenicity of Replacement Therapy for Hemophilia A. 2013.
MLA (9th ed.) CitationPandey, G., et al. Endogenous Factor VIII Synthesis from the Intron 22-inverted F8 Locus May Modulate the Immunogenicity of Replacement Therapy for Hemophilia A. 2013.
Warning: These citations may not always be 100% accurate.